148 related articles for article (PubMed ID: 11355044)
1. Effect of long-term hormone replacement therapy on angiotensin-converting enzyme activity and bradykinin in postmenopausal women with essential hypertension and normotensive postmenopausal women.
Nogawa N; Sumino H; Ichikawa S; Kumakura H; Takayama Y; Nakamura T; Kanda T; Mizunuma H; Kurabayashi M
Menopause; 2001; 8(3):210-5. PubMed ID: 11355044
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy in postmenopausal women with essential hypertension increases circulating plasma levels of bradykinin.
Sumino H; Ichikawa S; Kanda T; Sakamaki T; Nakamura T; Sato K; Kobayashi I; Nagai R
Am J Hypertens; 1999 Oct; 12(10 Pt 1):1044-7. PubMed ID: 10560792
[TBL] [Abstract][Full Text] [Related]
3. Effects of hormone replacement therapy on serum angiotensin-converting enzyme activity and plasma bradykinin in postmenopausal women according to angiotensin-converting enzyme-genotype.
Sumino H; Ichikawa S; Ohyama Y; Nakamura T; Kanda T; Sakamoto H; Sakamaki T; Mizunuma H; Kurabayashi M
Hypertens Res; 2003 Jan; 26(1):53-8. PubMed ID: 12661913
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy increases plasma level of angiotensin II in postmenopausal hypertensive women.
Umeda M; Ichikawa S; Kanda T; Sumino H; Kobayashi I
Am J Hypertens; 2001 Mar; 14(3):206-11. PubMed ID: 11281230
[TBL] [Abstract][Full Text] [Related]
5. Effects of hormone replacement therapy on blood coagulation and fibrinolysis in hypertensive and normotensive postmenopausal women.
Sumino H; Ichikawa S; Sawada Y; Sakamoto H; Kumakura H; Takayama Y; Sakamaki T; Kurabayashi M
Thromb Res; 2005; 115(5):359-66. PubMed ID: 15733968
[TBL] [Abstract][Full Text] [Related]
6. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
Ichikawa J; Sumino H; Ichikawa S; Ozaki M
Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
[TBL] [Abstract][Full Text] [Related]
7. Effects of long-term transdermal hormone replacement therapy on the renin-angiotensin- aldosterone system, plasma bradykinin levels and blood pressure in normotensive postmenopausal women.
Ichikawa A; Sumino H; Ogawa T; Ichikawa S; Nitta K
Geriatr Gerontol Int; 2008 Dec; 8(4):259-64. PubMed ID: 19149837
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II plays an important role in maintaining blood pressure in postmenopausal women receiving hormone replacement therapy.
Sumino H; Ichikawa S; Miya Y; Sakamaki T; Kurabayashi M
Am J Hypertens; 2005 Oct; 18(10):1340-6. PubMed ID: 16202859
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women.
Proudler AJ; Ahmed AI; Crook D; Fogelman I; Rymer JM; Stevenson JC
Lancet; 1995 Jul; 346(8967):89-90. PubMed ID: 7603219
[TBL] [Abstract][Full Text] [Related]
10. Conjugated estrogen plus medroxyprogesterone does not impair blood rheological properties in hypertensive postmenopausal women.
Sumino H; Ichikawa S; Takahashi T; Sakamoto H; Goto-Onozato K; Koya S; Kanda T; Nara M; Seki K; Murakami M; Kurabayashi M
Maturitas; 2006 Feb; 53(3):306-14. PubMed ID: 16040211
[TBL] [Abstract][Full Text] [Related]
11. Effects of hormone replacement therapy on left ventricular hypertrophy and growth-promoting factors in hypertensive postmenopausal women.
Miya Y; Sumino H; Ichikawa S; Nakamura T; Kanda T; Kumakura H; Takayama Y; Mizunuma H; Sakamaki T; Kurabayashi M
Hypertens Res; 2002 Mar; 25(2):153-9. PubMed ID: 12047028
[TBL] [Abstract][Full Text] [Related]
12. Effects of oestrogen-only and oestrogen-progestogen replacement therapy upon circulating angiotensin I-converting enzyme activity in postmenopausal women.
Proudler AJ; Cooper A; Whitehead M; Stevenson JC
Clin Endocrinol (Oxf); 2003 Jan; 58(1):30-5. PubMed ID: 12519409
[TBL] [Abstract][Full Text] [Related]
13. [The effect of alterations of the renin-angiotensin system and the sympathetic nervous system on plasma bradykinin concentration in patients with essential hypertension].
Takeda Y
Nihon Naibunpi Gakkai Zasshi; 1984 Sep; 60(9):1112-24. PubMed ID: 6097486
[TBL] [Abstract][Full Text] [Related]
14. Estrogen replacement therapy in postmenopausal women augments reactive hyperemia in the forearm by reducing angiotensin converting enzyme activity.
Sanada M; Higashi Y; Nakagawa K; Sasaki S; Kodama I; Sakashita T; Tsuda M; Ohama K
Atherosclerosis; 2001 Oct; 158(2):391-7. PubMed ID: 11583718
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy causes a decrease in hepatocyte growth factor in hypertensive women.
Tamama K; Sumino H; Ichikawa S; Kanda T; Kotajima N; Fukumura Y; Kurabayashi M; Murakami M
J Hypertens; 2003 Jun; 21(6):1151-6. PubMed ID: 12777952
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy, C-reactive protein, and fibrinogen in healthy postmenopausal women.
Yilmazer M; Fenkci V; Fenkci S; Sonmezer M; Aktepe O; Altindis M; Kurtay G
Maturitas; 2003 Dec; 46(4):245-53. PubMed ID: 14625121
[TBL] [Abstract][Full Text] [Related]
17. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement effects on endothelial function measured in the forearm resistance artery in normocholesterolemic and hypercholesterolemic postmenopausal women.
Sanada M; Higashi Y; Nakagawa K; Tsuda M; Kodama I; Kimura M; Chayama K; Ohama K
J Clin Endocrinol Metab; 2002 Oct; 87(10):4634-41. PubMed ID: 12364448
[TBL] [Abstract][Full Text] [Related]
19. Influence of chronic hormone replacement therapy on left ventricular mass and serum-ACE activity.
Manhem K; Ghanoum B; Johansson M; Milsom I; Gustafsson H
Blood Press; 2010 Oct; 19(5):295-300. PubMed ID: 20486868
[TBL] [Abstract][Full Text] [Related]
20. Effects of hormonal replacement therapy on oxidative stress and total antioxidant capacity in postmenopausal hemodialysis patients.
Chang SP; Yang WS; Lee SK; Min WK; Park JS; Kim SB
Ren Fail; 2002 Jan; 24(1):49-57. PubMed ID: 11921698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
